Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification

dc.contributor.authorFakhry, Maya
dc.contributor.authorSkafi, Najwa
dc.contributor.authorFayyad-Kazan, Mohammad
dc.contributor.authorKobeissy, Firas H.
dc.contributor.authorHamade, Eva
dc.contributor.authorMébarek, Saïda
dc.contributor.authorHabib, Aida A.
dc.contributor.authorBorghol, Nada
dc.contributor.authorZeidan, Asad
dc.contributor.authorMagne, David
dc.contributor.authorFayyad-kazan, Hussein
dc.contributor.authorBadran, Bassam M.
dc.contributor.departmentBiochemistry and Molecular Genetics
dc.contributor.departmentAnatomy, Cell Biology, and Physiological Sciences
dc.contributor.departmentDivision of Cardiology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:37:56Z
dc.date.available2025-01-24T11:37:56Z
dc.date.issued2018
dc.description.abstractMedial artery calcification, a hallmark of type 2 diabetes mellitus and chronic kidney disease (CKD), is known as an independent risk factor for cardiovascular mortality and morbidity. Hyperphosphatemia associated with CKD is a strong stimulator of vascular calcification but the molecular mechanisms regulating this process remain not fully understood. We showed that calcification was induced after exposing Sprague-Dawley rat aortic explants to high inorganic phosphate level (P i , 6 mM) as examined by Alizarin red and Von Kossa staining. This calcification was associated with high Tissue-Nonspecific Alkaline Phosphatase (TNAP) activity, vascular smooth muscle cells de-differentiation, manifested by downregulation of smooth muscle 22 alpha (SM22α) protein expression which was assessed by immunoblot analysis, immunofluorescence, and trans-differentiation into osteo-chondrocyte-like cells revealed by upregulation of Runt related transcription factor 2 (Runx2), TNAP, osteocalcin, and osteopontin mRNA levels which were determined by quantitative real-time PCR. To unravel the possible mechanism(s) involved in this process, microRNA (miR) expression profile, which was assessed using TLDA technique and thereafter confirmed by individual qRT-PCR, revealed differential expression 10 miRs, five at day 3 and 5 at day 6 post P i treatment versus control untreated aortas. At day 3, miR-200c, -155, 322 were upregulated and miR-708 and 331 were downregulated. After 6 days of treatment, miR-328, -546, -301a were upregulated while miR-409 and miR-542 were downregulated. Our results indicate that high P i levels trigger aortic calcification and modulation of certain miRs. These observations suggest that mechanisms regulating aortic calcification might involve miRs, which warrant further investigations in future studies. © 2017 Wiley Periodicals, Inc.
dc.identifier.doihttps://doi.org/10.1002/jcp.26121
dc.identifier.eid2-s2.0-85034073016
dc.identifier.pmid28776684
dc.identifier.urihttp://hdl.handle.net/10938/28928
dc.language.isoen
dc.publisherWiley-Liss Inc.
dc.relation.ispartofJournal of Cellular Physiology
dc.sourceScopus
dc.subjectAorta
dc.subjectCalcification
dc.subjectInorganic phosphate
dc.subjectMicrornas
dc.subjectTrans-differentiation
dc.subjectAlkaline phosphatase
dc.subjectAnimals
dc.subjectCalcification, physiologic
dc.subjectCell dedifferentiation
dc.subjectCore binding factor alpha 1 subunit
dc.subjectDiabetes mellitus, type 2
dc.subjectGene expression regulation
dc.subjectHumans
dc.subjectHyperphosphatemia
dc.subjectMicrofilament proteins
dc.subjectMuscle proteins
dc.subjectMuscle, smooth, vascular
dc.subjectOsteocalcin
dc.subjectPhosphates
dc.subjectRats
dc.subjectRenal insufficiency, chronic
dc.subjectAlpha smooth muscle actin
dc.subjectMessenger rna
dc.subjectMicrorna
dc.subjectMicrorna 107
dc.subjectMicrorna 133b
dc.subjectMicrorna 135a
dc.subjectMicrorna 155
dc.subjectMicrorna 186
dc.subjectMicrorna 200c
dc.subjectMicrorna 223
dc.subjectMicrorna 296
dc.subjectMicrorna 301a
dc.subjectMicrorna 322
dc.subjectMicrorna 323
dc.subjectMicrorna 328
dc.subjectMicrorna 331
dc.subjectMicrorna 345
dc.subjectMicrorna 375
dc.subjectMicrorna 409
dc.subjectMicrorna 491
dc.subjectMicrorna 542
dc.subjectMicrorna 546
dc.subjectMicrorna 598
dc.subjectMicrorna 708
dc.subjectOsteopontin
dc.subjectPhosphate
dc.subjectTissue nonspecific alkaline phosphatase
dc.subjectTranscription factor runx2
dc.subjectUnclassified drug
dc.subjectActin binding protein
dc.subjectAlpl protein, human
dc.subjectMirn328 microrna, rat
dc.subjectMuscle protein
dc.subjectRunx2 protein, rat
dc.subjectTransgelin
dc.subjectAlizarin red staining
dc.subjectAnimal experiment
dc.subjectAnimal tissue
dc.subjectArtery calcification
dc.subjectArticle
dc.subjectCell transdifferentiation
dc.subjectChondrocyte
dc.subjectControlled study
dc.subjectEnzyme activity
dc.subjectExplant
dc.subjectGene expression profiling
dc.subjectImmunoblotting
dc.subjectMale
dc.subjectNonhuman
dc.subjectPriority journal
dc.subjectProtein expression
dc.subjectRat
dc.subjectReal time polymerase chain reaction
dc.subjectSprague dawley rat
dc.subjectStaining
dc.subjectUpregulation
dc.subjectVascular smooth muscle cell
dc.subjectVon kossa staining
dc.subjectAnimal
dc.subjectBone mineralization
dc.subjectChronic kidney failure
dc.subjectDrug effect
dc.subjectGenetics
dc.subjectHuman
dc.subjectMetabolism
dc.subjectNon insulin dependent diabetes mellitus
dc.subjectPathology
dc.subjectPathophysiology
dc.subjectVascular smooth muscle
dc.titleCharacterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-8272.pdf
Size:
2.41 MB
Format:
Adobe Portable Document Format